Indefinite Delivery Contract W81K0023D0003
Award Date
10/1/23
Last Date to Order
6/30/28
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
W065 - Lease Or Rental Of Equipment- Medical, Dental, And Veterinary Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Health Agency (DHA), a defense agency, awarded an indefinite delivery contract (IDC) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The 5-year, $6,500,000 IDC provides DHA with an established means to acquire essential medical equipment and consumables from Roche on an as-needed basis.
Under this IDC, DHA has issued multiple firm fixed price delivery orders to Roche for the procurement of medical...
Roche Diagnostics Corporation has been awarded an indefinite delivery contract by the Department of the Army Medical Command to provide immunochemistry testing services. The single award contract has a potential value of $16.6M and period of performance through September 2023.
Under the contract vehicle, Roche has received multiple delivery orders to conduct clinical chemistry and immunoassay testing at its facility in Castleton, Indiana for various Army medical treatment facilities. Orders...
This federal contract IDV award was issued by the U.S. Army Medical Command (MEDCOM), a defense agency, to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The single-award Indefinite Delivery Contract has a ceiling value of $10.9M and a period of performance through September 30, 2028.
The contract provides for the delivery of clinical chemistry analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to VA hospitals, military...
The Department of Veterans Affairs Veterans Health Administration has awarded Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a single-award indefinite delivery contract (IDC) to provide Roche brand reagents and consumables. The $100,685.04 firm fixed price delivery order has a period of performance through February 2027 and does not utilize any set-asides. Roche Diagnostics Corp, a foreign-owned for-profit manufacturer, is an established federal contractor that has...
Roche Diagnostics Corporation has been awarded a single award blanket purchase agreement by the Defense Health Agency to provide laboratory testing reagents and a cell stainer. The potential value of the BPA is $129,021.70 through April 2024.
A firm fixed price call was placed against the BPA for $15,314.77 to supply reagents supporting DHA programs. The reagents will be delivered to a facility in Castleton, Indiana with performance through September 2023. As the prime contractor, Roche...
Roche Diagnostics Corporation has been awarded a blanket purchase agreement as a single-award indefinite-delivery contract vehicle by the Department of the Army Medical Command to provide cell staining supplies. Task orders issued against the agreement by the Defense Health Agency include diagnostic supplies valued at approximately $20,691, biopsy reagents valued at $13,763.54, and test kits valued at $14,181.97. All task orders were firm-fixed-price and included no set-aside designations,...
This Indefinite Delivery Contract (IDC) award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, provides the Defense Health Agency (DHA) with a long-term vehicle to acquire various laboratory instruments, reagents, test kits, and associated products and services. The $1.77 million ceiling value contract has a period of performance through September 2026.
Multiple delivery orders have been placed against this IDC, including $354,965 for Roche reagents in FY 2023,...
Abbott Laboratories Inc., through its Abbott Diagnostics Division, has been awarded an indefinite delivery contract by the Defense Health Agency to provide immunochemistry reagents. The contract has a potential value of $3.78 million and a period of performance through September 2023. Task orders issued to date include a $1.4 million order for the Defense Health Agency and orders valued at $1.89 million and $1.2 million for the Department of the Army Medical Command. Performance will take...
The provided information details an Indefinite Delivery Contract (IDC) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and associated products and services.
The 5-year, $9,160,241.71 IDC allows DHA to issue delivery orders for Roche's Total Laboratory Automation Systems and Cobas 8000 analyzers to support operations at Madigan Army Medical Center in Tacoma, Washington. Under the IDC,...
This series of Blanket Purchase Agreement (BPA) awards to Roche Diagnostics Corporation provide the U.S. Department of Defense's Defense Health Agency (DHA) and Air Force Life Cycle Management Center (AFLCMC) with critical medical equipment, reagents, and consumables to support laboratory operations at military treatment facilities and the U.S. Air Force School of Aerospace Medicine (USAFSAM) Epidemiology Laboratory.
The BPA awards, issued against Roche's existing General Services...